Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 285

1.

Bisphosphonates and jaw osteonecrosis: the UAMS experience.

Clarke BM, Boyette J, Vural E, Suen JY, Anaissie EJ, Stack BC Jr.

Otolaryngol Head Neck Surg. 2007 Mar;136(3):396-400.

PMID:
17321866
2.
3.

Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.

Bamias A, Kastritis E, Bamia C, Moulopoulos LA, Melakopoulos I, Bozas G, Koutsoukou V, Gika D, Anagnostopoulos A, Papadimitriou C, Terpos E, Dimopoulos MA.

J Clin Oncol. 2005 Dec 1;23(34):8580-7.

PMID:
16314620
4.

Osteonecrosis of the jaw in patients on bisphosphonate treatment. review of literature with contribution of a case of multiple myeloma.

Goranova-Marinova VS, Pechalova-Petrova PF, Goranov SG.

Folia Med (Plovdiv). 2009 Oct-Dec;51(4):53-7.

PMID:
20232660
5.

Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.

King AE, Umland EM.

Pharmacotherapy. 2008 May;28(5):667-77. doi: 10.1592/phco.28.5.667. Review.

PMID:
18447663
6.

Bisphosphonate-associated osteonecrosis of the jaw: conclusions based on an analysis of case series.

Landesberg R, Wilson T, Grbic JT.

Dent Today. 2006 Aug;25(8):52, 54-7.

PMID:
16925161
7.

Hyperbaric oxygen treatment and bisphosphonate-induced osteonecrosis of the jaw: a case series.

Freiberger JJ, Padilla-Burgos R, Chhoeu AH, Kraft KH, Boneta O, Moon RE, Piantadosi CA.

J Oral Maxillofac Surg. 2007 Jul;65(7):1321-7.

PMID:
17577496
8.

Osteonecrosis of the jaw correlated to bisphosphonate therapy in non-oncologic patients: clinicopathological features of 24 patients.

Favia G, Pilolli GP, Maiorano E.

J Rheumatol. 2009 Dec;36(12):2780-7. doi: 10.3899/jrheum.090455. Epub 2009 Nov 2.

PMID:
19884275
9.

Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid.

Dimopoulos MA, Kastritis E, Anagnostopoulos A, Melakopoulos I, Gika D, Moulopoulos LA, Bamia C, Terpos E, Tsionos K, Bamias A.

Haematologica. 2006 Jul;91(7):968-71. Epub 2006 Jun 1.

10.

[Bisphosphonates and osteonecrosis of the jaws in patients with myelomatosis].

Neumann B, Gregersen H.

Ugeskr Laeger. 2006 May 22;168(21):2078-9. Danish.

PMID:
16768928
11.

Bisphosphonate-associated osteonecrosis of the jaws: the limits of a conservative approach.

Tirelli G, Biasotto M, Chiandussi S, Dore F, De Nardi E, Di Lenarda R.

Head Neck. 2009 Sep;31(9):1249-54. doi: 10.1002/hed.21019.

PMID:
19260132
12.

[Osteonecrosis of the jaw associated with the use of bisphosphonates in multiple myeloma: report of four cases and literature review].

Li LH, Wu XB, Chen WM, Chen JX, Wu Y, Chen SL.

Zhonghua Yi Xue Za Zhi. 2008 Nov 18;88(42):2986-7. Review. Chinese.

PMID:
19080077
13.

"Bis-phossy jaws" - high and low risk factors for bisphosphonate-induced osteonecrosis of the jaw.

Abu-Id MH, Warnke PH, Gottschalk J, Springer I, Wiltfang J, Acil Y, Russo PA, Kreusch T.

J Craniomaxillofac Surg. 2008 Mar;36(2):95-103. doi: 10.1016/j.jcms.2007.06.008. Epub 2008 Jan 30.

PMID:
18234504
14.

Bisphosphonate-induced osteonecrosis of the jaw: long-term outcomes.

Katz J, George T, Sandow P, Machado M, Dickerson L, Moreb JS.

J Support Oncol. 2009 Jan-Feb;7(1):9-10. No abstract available.

PMID:
19278171
15.

Bisphosphonate-associated osteonecrosis of the jaw: does it occur in children?

Brown JJ, Ramalingam L, Zacharin MR.

Clin Endocrinol (Oxf). 2008 Jun;68(6):863-7. doi: 10.1111/j.1365-2265.2008.03189.x. Epub 2008 Jan 21.

PMID:
18221397
16.

Jaw bone necrosis without previous dental extractions associated with the use of bisphosphonates (pamidronate and zoledronate): a four-case report.

Merigo E, Manfredi M, Meleti M, Corradi D, Vescovi P.

J Oral Pathol Med. 2005 Nov;34(10):613-7.

PMID:
16202082
17.

Prevalence and risk factors of bisphosphonate-associated osteonecrosis of the jaw in prostate cancer patients with advanced disease treated with zoledronate.

Walter C, Al-Nawas B, Grötz KA, Thomas C, Thüroff JW, Zinser V, Gamm H, Beck J, Wagner W.

Eur Urol. 2008 Nov;54(5):1066-72. doi: 10.1016/j.eururo.2008.06.070. Epub 2008 Jun 26.

PMID:
18602738
18.

Incidence of osteonecrosis of the jaw in patients with multiple myeloma and breast or prostate cancer on intravenous bisphosphonate therapy.

Wang EP, Kaban LB, Strewler GJ, Raje N, Troulis MJ.

J Oral Maxillofac Surg. 2007 Jul;65(7):1328-31.

PMID:
17577497
19.

Osteonecrosis of the jaw associated with bisphosphonate use: Presentation of seven cases and literature review.

Mortensen M, Lawson W, Montazem A.

Laryngoscope. 2007 Jan;117(1):30-4. Review.

PMID:
17202926
20.

Osteonecrosis of the maxilla and mandible in patients with advanced cancer treated with bisphosphonate therapy.

Estilo CL, Van Poznak CH, Wiliams T, Bohle GC, Lwin PT, Zhou Q, Riedel ER, Carlson DL, Schoder H, Farooki A, Fornier M, Halpern JL, Tunick SJ, Huryn JM.

Oncologist. 2008 Aug;13(8):911-20. doi: 10.1634/theoncologist.2008-0091. Epub 2008 Aug 11.

Supplemental Content

Support Center